Back
Vaxart Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
28
VXRT
Vaxart
Last Price:
0.79
Seasonality Move:
6.43%
Buy
64
PLX
Protalix BioTherapeutics
Last Price:
1.18
Seasonality Move:
66.95%
Sell
28
Vaxart (VXRT)
is a Sell
Is Vaxart a Buy, Sell or Hold?
- The current Vaxart [VXRT] share price is $0.80. The Score for VXRT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- VXRT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.17. The Score for PLX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VXRT Stock Price Chart
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
VXRT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.25 | Sell |
| Chaikin Money Flow: | -752388 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.79 - 0.83) | Sell |
| Bollinger Bands (100): | (0.65 - 0.87) | Buy |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 64.48 | Buy |
| Chaikin Money Flow: | -127811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.1) | Buy |
| Bollinger Bands (100): | (0.99 - 1.15) | Buy |
VXRT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.8 | Sell |
| 20-day SMA: | 0.8 | Sell |
| 50-day SMA: | 0.85 | Sell |
| 200-day SMA: | 0.88 | Sell |
| 8-day EMA: | 0.8 | Sell |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.81 | Sell |
| 200-day EMA: | 0.84 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Buy |
| 20-day SMA: | 1.06 | Buy |
| 50-day SMA: | 1.04 | Buy |
| 200-day SMA: | 1.2 | Sell |
| 8-day EMA: | 1.09 | Buy |
| 20-day EMA: | 1.07 | Buy |
| 50-day EMA: | 1.06 | Buy |
| 200-day EMA: | 1.2 | Sell |
Vaxart Earnings Growth & VXRT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.06 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vaxart Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||